• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.03% Nasdaq Up0.33%

    More On TOS.TO

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    TSO3 Inc. (TOS.TO)

    -Toronto
    1.93 Down 0.01(0.52%) 3:59PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    TSO3 Inc.
    2505, Avenue Dalton
    Quebec, QC G1P 3S5
    Canada - Map
    Phone: 418-651-0003
    Fax: 418-653-5726
    Website: http://www.tso3.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Medical Instruments & Supplies
    Full Time Employees:37

    Business Summary 

    TSO3 Inc. engages in the research, development, production, maintenance, sale, and licensing of sterilization processes, related consumable supplies, and accessories for heat-sensitive medical devices in Canada and internationally. It offers sterilizers, related spare parts and maintenance services, consumable supplies, accessories, and compatibility testing services. The company’s products include the STERIZONE VP4 Sterilizer, a dual sterilant, low temperature sterilization system that utilizes vaporized hydrogen peroxide and ozone; and the STERIZONE 125L+ Sterilizer, which is designed for terminal sterilization of heat- and moisture-sensitive medical devices, and is intended for the reprocessing of general instruments, rigid channel instruments, single/multi-channel rigid endoscopes, as well as short and long single/multi-channel flexible endoscopes. It also provides product development services to medical device manufacturers that include hydrogen peroxide and ozone sterilization validation, compatibility testing, medical devices cleaning method development, and medical packaging compatibility verification. The company was founded in 1998 and is headquartered in Quebec, Canada.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on TSO3 Inc.

    Key Executives 
     PayExercised
    Mr. Richard M. Rumble , 56
    Chief Exec. Officer, Pres, Director and Chairman of Advisory Committee
    N/AN/A
    Dr. Beno Deschamps MBA, Ph.D., 63
    Chief Financial Officer, VP of Fin. and Sec.
    N/AN/A
    Mr. Daniel Rivard ,
    VP of Operations
    N/AN/A
    Mr. James Wetzel ,
    VP of Sales and Marketing
    N/AN/A
    Mr. Henri Bousquet ,
    Director of Marketing
    N/AN/A
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in CAD.